Company Intelligence
Macromoltek
Macromoltek provides enterprise-grade artificial intelligence solutions, delivering specialized Computational antibody design technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- Austin, United States
- Website
- www.macromoltek.com
- Founded
- 2018
- Employees
- 14
- Stage
- Early
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Macromoltek is a Healthcare AI company based in Austin, United States, founded in 2018.
Macromoltek develops computational antibody design.
What it does
Through the deployment of Computational antibody design, Macromoltek provides computational automation and data intelligence for organizations operating in Artificial Intelligence.
What it builds
Computational antibody design
Why It Matters
Macromoltek provides enterprise-grade artificial intelligence solutions, delivering specialized Computational antibody design technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
Macromoltek
Explore Macromoltek by Macromoltek. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture, and FAQs.
View product intelligence
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Macromoltek
Industry
Products
Capabilities
- Computational antibody design
Country
Official Resources
Official and developer links on file for this company.
Frequently Asked Questions
What does Macromoltek do?
Macromoltek specializes in artificial intelligence, developing Computational antibody design to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Macromoltek based and when was it founded?
Macromoltek is based in United States and was founded in 2018.
What are the main products offered by Macromoltek?
The flagship platform from Macromoltek is Computational antibody design, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Macromoltek?
Macromoltek primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.